Federated Hermes’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-227,187
| Closed | -$4.58M | – | 2370 |
|
|
2021
Q3 | $4.58M | Sell |
227,187
-167,114
| -42% | -$4.61M | 0.01% | 844 |
|
|
2021
Q2 | $14.7M | Buy |
394,301
+182,823
| +86% | +$5.6M | 0.03% | 556 |
|
|
2021
Q1 | $5.41M | Buy |
211,478
+211,208
| +78,225% | +$5.39M | 0.01% | 832 |
|
|
2020
Q4 | $6K | Sell |
270
-107,990
| -100% | -$2.38M | ﹤0.01% | 2040 |
|
|
2020
Q3 | $1.95M | Sell |
108,260
-10,136
| -9% | -$210K | ﹤0.01% | 999 |
|
|
2020
Q2 | $3.01M | Sell |
118,396
-38,209
| -24% | -$823K | 0.01% | 853 |
|
|
2020
Q1 | $2.88M | Sell |
156,605
-206,111
| -57% | -$4.01M | 0.01% | 786 |
|
|
2019
Q4 | $7.99M | Buy |
362,716
+228,929
| +171% | +$4.61M | 0.02% | 648 |
|
|
2019
Q3 | $1.92M | Buy |
+133,787
| New | +$1.91M | ﹤0.01% | 1047 |
|
|
2019
Q2 | – | Sell |
-287,961
| Closed | -$4.22M | – | 2255 |
|
|
2019
Q1 | $4.22M | Sell |
287,961
-43,592
| -13% | -$501K | 0.01% | 828 |
|
|
2018
Q4 | $3.54M | Buy |
331,553
+79,058
| +31% | +$1.04M | 0.01% | 840 |
|
|
2018
Q3 | $3.85M | Buy |
252,495
+252,085
| +61,484% | +$3.67M | 0.01% | 880 |
|
|
2018
Q2 | $5K | Buy |
+410
| New | +$5.15K | ﹤0.01% | 2025 |
|
|
2017
Q3 | – | Sell |
-541
| Closed | -$2K | – | 2212 |
|
|
2017
Q2 | $2K | Sell |
541
-1,000
| -65% | -$3.16K | ﹤0.01% | 2059 |
|
|
2017
Q1 | $5K | Hold |
1,541
| – | – | ﹤0.01% | 1949 |
|
|
2016
Q4 | $4K | Buy |
1,541
+1,324
| +610% | +$4.71K | ﹤0.01% | 1975 |
|
|
2016
Q3 | $1K | Buy |
+217
| New | +$761 | ﹤0.01% | 2094 |
|
|
2015
Q3 | – | Sell |
-67
| Closed | -$1K | – | 2081 |
|
|
2015
Q2 | $1K | Sell |
67
-264
| -80% | -$4.84K | ﹤0.01% | 1922 |
|
|
2015
Q1 | $8K | Buy |
+331
| New | +$7.44K | ﹤0.01% | 1808 |
|
Other funds holding DRNA
Federated Hermes's DRNA Position: Q4 2021 in Review
Federated Hermes sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 227,187 shares — an estimated $4.58M sold.
Federated Hermes first reported a position in DRNA in Q1 2015 and held it in 19 quarters. The position peaked at $14.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Federated Hermes reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Federated Hermes sold 227,187 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $4.58M.
- Federated Hermes first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2015 and held it in 19 quarters.
- Federated Hermes's Dicerna Pharmaceuticals, Inc. position peaked at $14.7M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.